Hereditary hemorrhagic telangiectasia, factor V leiden and antiphospholipid syndrome: A case report

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 1, 2002, Pages 53-56

  Undas, A ^a   Bazan Socha, S ^a   Swadzba, J ^a   Musial, J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antiphospholipid antibodies; Cerebral stroke; Factor V Leiden; Hereditary hemorrhagic telangiectasia

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTHROMBIN ANTIBODY; TICLOPIDINE;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CARRIER; EPISTAXIS; FEMALE; GENE MUTATION; HUMAN; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; THROMBOPHILIA; TREATMENT INDICATION;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; CEREBROVASCULAR ACCIDENT; FACTOR V; FEMALE; HUMANS; ISCHEMIA; MIDDLE AGED; PEDIGREE; PLATELET AGGREGATION INHIBITORS; PROTHROMBIN; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; THROMBOPHILIA; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0036234525     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200201000-00008     Document Type: Article

References (12)

1. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
2. Hereditary haemorrhagic telegiectasia: A population-based study of prevalence and mortality in Danish patients
3. World distribution of factor V Leiden
4. Cerebrovascular diseases with antiphospholipid antibodies: Immune mechanisms, significance, and therapeutic options
5. 2-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis
6. Laboratory identification of lupus anticoagulants: Results of the Second International Workshop for Identification of Lupus Anticoagulants
7. Disseminated lupus erythematosus associated with Rendu-Osler disease. Antiphospholipid antibodies don't protect from hemorrhage
8. Ischemic cerebrovascular complications in Rendu-Osler disease: A case
9. Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?
10. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischaemic stroke in children
11. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
12. Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies - Prevalence and significance